Advertisement
News
Advertisement

ImmunoGen begins clinical tests of cancer treatment

Tue, 09/21/2010 - 11:32am
Mass High Tech: The Journal of New England Technology

ImmunoGen Inc. has begun clinical testing of its drug candidate SAR566658 in treating ovarian, breast, cervical, lung and pancreatic cancers.

The Cambridge biotech has worked with Paris pharmaceutical giant Sanofi-aventis to co-develop SAR566658, which uses ImmunoGen’s Targeted Antibody Payload technology. The technology has prompted a $1 million milestone payment from Sanofi-aventis, which has started clinical evaluations, to ImmunoGen (Nasdaq: IMGN).

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading